Core Scientific: Walking Away

Core Scientific (CORZ) is trading at all-time highs ahead of a key shareholder vote on its proposed merger with CoreWeave, which is widely perceived to undervalue CORZ shares through its fixed exchange ratio. Analysts and proxy advisors are recommending a 'No' vote, with Roth Capital upgrading CORZ to a Buy rating and a $23.50 price target, anticipating robust AI infrastructure growth and new contracts if the merger is rejected.

Analysis

Core Scientific (CORZ) is currently trading at all-time highs ahead of a pivotal shareholder vote on its proposed merger with CoreWeave. The market widely views the fixed exchange ratio as significantly undervaluing CORZ shares, fueling speculation that the deal will be rejected. This sentiment is further supported by the outperformance of peers like IREN and WULF, suggesting a preference for independent growth in the sector.

Analysts and proxy advisors are advocating for a "No" vote on the merger, with Roth Capital upgrading CORZ to a Buy rating and setting a $23.50 price target. This reflects a strong belief in the company's intrinsic value and future prospects if it remains independent, aligning with the overall bullish tone observed.

Despite mixed Q3 results, CORZ's growth trajectory in AI infrastructure and its potential to secure new contracts are considered robust. A merger cancellation is thus seen as a significant catalyst, allowing CORZ to capitalize on its strategic positioning in the high-demand AI sector and unlock shareholder value.

Key Decisions for Investors

• Closely monitor the upcoming shareholder vote on the CoreWeave merger, as its rejection is widely anticipated to be a significant positive catalyst for CORZ shares.
• Assess Core Scientific's standalone growth potential within the AI infrastructure sector, considering the analyst-backed $23.50 price target and potential for new contracts.
• Evaluate the current market valuation of CORZ relative to the proposed fixed exchange ratio, recognizing the perceived undervaluation embedded in the merger terms.